发明名称 Methods for detecting LP-PLA2 activity and inhibition of LP-PLA2 activity
摘要 This invention relates to methods for determining the activity of Lp-PLA2 in at least one sample from an animal. The invention also relates to methods for determining the inhibition of Lp-PLA2 activity in samples from animals that are administered an Lp-PLA2 inhibitor.
申请公布号 US9465029(B2) 申请公布日期 2016.10.11
申请号 US201514700053 申请日期 2015.04.29
申请人 Glaxo Group Limited 发明人 Shou Yaping;Siu Yin Fai Amy;Walker George T.
分类号 G01N33/573;C12Q1/44;G01N33/58 主分类号 G01N33/573
代理机构 代理人 Sauermelch Loretta J.;Gimmi Edward R.
主权项 1. A colorimetric method of determining the percentage of inhibition of Lp-PLA2 activity, the method comprising: preparing a solution comprising a substrate for Lp-PLA2 having a colorimetric detectable moiety, which substrate is 1-myristoyl-2-(4-nitrophenylsuccinyl)phosphatidylcholine; contacting a first blood sample that is taken from a human subject at a first time with the solution; colorimetrically detecting Lp-PLA2 activity from the first blood sample wherein the first blood sample is diluted less than 33 times; contacting a second blood sample that is taken from the subject at a second time one hour or more after the first time with the solution, wherein the second blood sample is taken after the subject has been administered a drug that inhibits Lp-PLA2; colorimetrically detecting Lp-PLA2 activity from the second blood sample wherein the second blood sample is diluted less than 33 times; and detecting greater than 30% inhibition of Lp-PLA2 activity between the first and second blood samples by comparing the activity of the Lp-PLA2 between the first and second blood samples, indicating that the subject has taken a drug that inhibits Lp-PLA2.
地址 Middlesex GB